Urinary Biomarkers for Neurodegenerative Diseases
نویسندگان
چکیده
منابع مشابه
Biomarkers in Neurodegenerative Diseases: Cortisol
Neurodegenerative diseases are characterized by progressive loss of cognitive function, dementia, and problems with movements. Identification of biomarkers during disease process, induce to an effective and early diagnostic test for neurodegenerative diseases. These biomarkers would allow presymptomatic disease detection of disease and would be valuable for monitoring the efficacy of disease. C...
متن کاملImaging biomarkers in neurodegenerative diseases
One way to think about neurodegenerative diseases is to divide them into those that are and those that are not typically associated with dementia. For example Alzheimer’s disease (AD) is while amyotrophic lateral sclerosis or certain movement disorders are typically not associated with dementia. This talk will focus on neurodegeneration that is associated with dementia in the elderly. There are...
متن کاملcNEUPRO: Novel Biomarkers for Neurodegenerative Diseases
"clinical NEUroPROteomics of neurodegenerative diseases" (cNEUPRO) is a Specific Targeted Research Project (STREP) within the sixth framework program of the European Commission dedicated to the search for novel biomarker candidates for Alzheimer's disease and other neurodegenerative diseases. The ultimate goal of cNEUPRO is to identify one or more valid biomarker(s) in blood and CSF applicable ...
متن کاملUrinary Biomarkers of Brain Diseases
Biomarkers are the measurable changes associated with a physiological or pathophysiological process. Unlike blood, urine is not subject to homeostatic mechanisms. Therefore, greater fluctuations could occur in urine than in blood, better reflecting the changes in human body. The roadmap of urine biomarker era was proposed. Although urine analysis has been attempted for clinical diagnosis, and u...
متن کاملProteomics/peptidomics tools to find CSF biomarkers for neurodegenerative diseases.
Neurodegenerative diseases are characterized by premature neuronal loss in specific brain regions. During the past decades our knowledge on molecular mechanisms underlying neurodegeneration has increased immensely and resulted in promising drug candidates that might slow down or even stop the neuronal loss. These advances have put a strong focus on the development of diagnostic tools for early ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Experimental Neurobiology
سال: 2020
ISSN: 1226-2560,2093-8144
DOI: 10.5607/en20042